Menopause in Women, Andropause in Men: Myth, Reality, and Management

This paper examines menopause in women and the concept of "male menopause," focusing on the biological and clinical aspects of midlife endocrine changes. Menopause is identified as a clear transition with ovarian failure and loss of hormones, leading to symptoms like vasomotor issues and increased bone and cardiovascular risks. In contrast, male ageing involves a gradual decline in testosterone, with only some men experiencing symptomatic Late-Onset Hypogonadism (LOH), characterized by sexual dysfunction and mood disturbances. The paper discusses diagnostic challenges and management strategies for LOH, emphasizing lifestyle changes and targeted testosterone therapy. It calls for a comprehensive approach to midlife endocrine changes, integrating lifestyle, endocrine, and psychosocial care to improve outcomes for both genders.